523 related articles for article (PubMed ID: 9568692)
1. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
Dittler J; Seidel D; Schenker M; Ziegler AG
Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus.
Borg H; Fernlund P; Sundkvist G
Clin Chem; 1997 Dec; 43(12):2358-63. PubMed ID: 9439455
[TBL] [Abstract][Full Text] [Related]
3. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes.
Mayrhofer M; Rabin DU; Messenger L; Standl E; Ziegler AG
Exp Clin Endocrinol Diabetes; 1996; 104(3):228-34. PubMed ID: 8817240
[TBL] [Abstract][Full Text] [Related]
4. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
[TBL] [Abstract][Full Text] [Related]
5. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus.
Gupta M; Graham J; McNeeny B; Zarghami M; Landin-Olsson M; Hagopian WA; Palmer J; Lernmark A; Sanjeevi CB
Ann N Y Acad Sci; 2006 Oct; 1079():229-39. PubMed ID: 17130560
[TBL] [Abstract][Full Text] [Related]
6. The Melbourne Pre-Diabetes Study: prediction of type 1 diabetes mellitus using antibody and metabolic testing.
Colman PG; McNair P; Margetts H; Schmidli RS; Werther GA; Alford FP; Ward GM; Tait BD; Honeyman MC; Harrison LC
Med J Aust; 1998 Jul; 169(2):81-4. PubMed ID: 9700342
[TBL] [Abstract][Full Text] [Related]
7. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins.
Christie MR; Roll U; Payton MA; Hatfield EC; Ziegler AG
Diabetes Care; 1997 Jun; 20(6):965-70. PubMed ID: 9167107
[TBL] [Abstract][Full Text] [Related]
8. IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.
Savola K; Bonifacio E; Sabbah E; Kulmala P; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Meriläinen J; Akerblom HK; Knip M
Diabetologia; 1998 Apr; 41(4):424-9. PubMed ID: 9562346
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening.
Sera Y; Kawasaki E; Abiru N; Ozaki M; Abe T; Takino H; Kondo H; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S; Uchigata Y; Matsuura N; Eguchi K
J Autoimmun; 1999 Sep; 13(2):257-65. PubMed ID: 10479394
[TBL] [Abstract][Full Text] [Related]
10. Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study.
Füchtenbusch M; Ferber K; Standl E; Ziegler AG
Diabetes; 1997 Sep; 46(9):1459-67. PubMed ID: 9287047
[TBL] [Abstract][Full Text] [Related]
11. Influence of sex and age at onset on autoantibodies against insulin, GAD65 and IA2 in recent onset type 1 diabetic patients.
Bilbao JR; Rica I; Vázquez JA; Busturia MA; Castaño L
Horm Res; 2000; 54(4):181-5. PubMed ID: 11416235
[TBL] [Abstract][Full Text] [Related]
12. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group.
Kulmala P; Savola K; Petersen JS; Vähäsalo P; Karjalainen J; Löppönen T; Dyrberg T; Akerblom HK; Knip M
J Clin Invest; 1998 Jan; 101(2):327-36. PubMed ID: 9435304
[TBL] [Abstract][Full Text] [Related]
13. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
[TBL] [Abstract][Full Text] [Related]
14. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
[TBL] [Abstract][Full Text] [Related]
15. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
[TBL] [Abstract][Full Text] [Related]
16. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
Seissler J; Atik Y; Klinghammer A; Scherbaum WA
Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
[TBL] [Abstract][Full Text] [Related]
17. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
Knip M; Karjalainen J; Akerblom HK
Diabetes Care; 1998 Oct; 21(10):1670-3. PubMed ID: 9773728
[TBL] [Abstract][Full Text] [Related]
18. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
[TBL] [Abstract][Full Text] [Related]
19. Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/IA2 antibodies after diagnosis of diabetes.
Borg H; Marcus C; Sjöblad S; Fernlund P; Sundkvist G
Acta Paediatr; 2000 Jan; 89(1):46-51. PubMed ID: 10677057
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome.
Morgenthaler NG; Seissler J; Achenbach P; Glawe D; Payton M; Meinck HM; Christie MR; Scherbaum WA
Autoimmunity; 1997; 25(4):203-11. PubMed ID: 9344328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
